Company: NDRA
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001654954-25-005770
Chunk: 52

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 4
Chunk 52
---
ley Act of 2002 (furnished herewith)101.INS XBRL Instance Document (filed herewith)101.SCH XBRL Taxonomy Schema (filed herewith)101.CAL XBRL Taxonomy Extension Calculation Linkbase (filed herewith)101.DEF XBRL Taxonomy Extension Definition Linkbase (filed herewith)101.LAB XBRL Taxonomy Extension Label Linkbase (filed herewith)101.PRE XBRL Taxonomy Extension Presentation Linkbase (filed herewith)

* Indicates management compensatory plan, contract or arrangement.

 23Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 ENDRA LIFE SCIENCES INC.    Date: May 15, 2025By:/s/ Alexander Tokman   Alexander Tokman   Chief Executive Officer and Chairman(Principal Executive Officer) 

 ENDRA LIFE SCIENCES INC.     Date: May 15, 2025By:/s/ Richard Jacroux   Richard Jacroux   Chief Financial Officer(Principal Financial and Accounting Officer) 

 24